CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria

Published 2019 View Full Article

Authors

Keywords

Histamine, H<sub>1</sub>-antihistamines, Diphenhydramine, CSACI position statement

Journal

Allergy Asthma and Clinical Immunology

Volume 15, Issue 1, Pages -

Publisher

Springer Science and Business Media LLC

Online

2019-10-01

DOI

10.1186/s13223-019-0375-9

References

View 13 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started